Concerns about medications mediate the association of posttraumatic stress disorder with adherence to medication in stroke survivors

被引:30
作者
Edmondson, Donald [1 ]
Horowitz, Carol R. [2 ]
Goldfinger, Judith Z. [2 ]
Fei, Kezhen [3 ]
Kronish, Ian M. [1 ]
机构
[1] Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY 10032 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY USA
[3] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY USA
关键词
ANXIETY BUFFER DISRUPTION; MODIFIED RANKIN SCALE; QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; SYMPTOMS; NONADHERENCE; PREVENTION; DEPRESSION; VALIDITY; OUTCOMES;
D O I
10.1111/bjhp.12022
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
ObjectivesPost-traumatic stress disorder (PTSD) can be a consequence of acute medical events and has been associated with non-adherence to medications. We tested whether increased concerns about medications could explain the association between PTSD and non-adherence to medication in stroke survivors. DesignWe surveyed 535 participants aged 40years or older who had at least one stroke or transient ischaemic attack in the previous 5years. MethodsWe assessed PTSD using the PTSD checklist-specific for stroke, medication adherence with the Morisky Medication Adherence Questionnaire, and beliefs about medications with the Beliefs about Medicines Questionnaire. We used logistic regression to test whether concerns about medications mediated the association between stroke-induced PTSD and non-adherence to medication. Covariates for adjusted analyses included age, sex, race, comorbid medical conditions, stroke-related disability, years since last stroke/TIA, and depression. ResultsSymptoms of PTSD were correlated with greater concerns about medications (r=0.45; p<.001), and both were associated with medication non-adherence. Adjustment for concerns about medications attenuated the relationship between PTSD and non-adherence to medication, from an odds ratio [OR] of 1.04 (95% confidence interval [CI], 1.01-1.06; OR, 1.63 per 1 SD) to an OR of 1.02 (95% CI, 1.00-1.05; OR, 1.32 per 1 SD), and increased concerns about medications remained associated with increased odds of non-adherence to medication (OR, 1.17; 95% CI, 1.10-1.25; OR, 1.72 per 1 SD) in this fully adjusted model. A bootstrap mediation test suggested that the indirect effect was statistically significant and explained 38% of the association of PTSD to medication non-adherence, and the direct effect of PTSD symptoms on medication non-adherence was no longer significant. ConclusionIncreased concerns about medications explain a significant proportion of the association between PTSD symptoms and non-adherence to medication in stroke survivors.
引用
收藏
页码:799 / 813
页数:15
相关论文
共 53 条
[1]   Posttraumatic Stress Reactions as a Disruption in Anxiety-Buffer Functioning: Dissociation and Responses to Mortality Salience as Predictors of Severity of Posttraumatic Symptoms [J].
Abdollahi, Abdolhossein ;
Pyszczynski, Tom ;
Maxfield, Molly ;
Luszczynska, Aleksandra .
PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2011, 3 (04) :329-341
[2]   Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD checklist - Civilian version (PCL-C) as a screening instrument [J].
Andrykowski, MA ;
Cordova, MJ ;
Studts, JL ;
Miller, TW .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1998, 66 (03) :586-590
[3]   Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials - A literature review and synthesis [J].
Banks, Jamie L. ;
Marotta, Charles A. .
STROKE, 2007, 38 (03) :1091-1096
[4]   Secondary preventive medication persistence and adherence 1 year after stroke [J].
Bushnell, C. D. ;
Olson, D. M. ;
Zhao, X. ;
Pan, W. ;
Zimmer, L. O. ;
Goldstein, L. B. ;
Alberts, M. J. ;
Fagan, S. C. ;
Fonarow, G. C. ;
Johnston, S. C. ;
Kidwell, C. ;
LaBresh, K. A. ;
Ovbiagele, B. ;
Schwamm, L. ;
Peterson, E. D. .
NEUROLOGY, 2011, 77 (12) :1182-1190
[5]   Persistence With Stroke Prevention Medications 3 Months After Hospitalization [J].
Bushnell, Cheryl D. ;
Zimmer, Louise O. ;
Pan, Wenqin ;
Olson, DaiWai M. ;
Zhao, Xin ;
Meteleva, Tatiana ;
Schwamm, Lee ;
Ovbiagele, Bruce ;
Williams, Linda ;
LaBresh, Kenneth A. ;
Peterson, Eric D. .
ARCHIVES OF NEUROLOGY, 2010, 67 (12) :1456-1463
[6]   Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease [J].
Catz, SL ;
Kelly, JA ;
Bogart, LM ;
Benotsch, EG ;
McAuliffe, TL .
HEALTH PSYCHOLOGY, 2000, 19 (02) :124-133
[7]   Adherence to medication in stroke survivors: A qualitative comparison of low and high adherers [J].
Chambers, Julie A. ;
O'Carroll, Ronan E. ;
Hamilton, Barbara ;
Whittaker, Jennifer ;
Johnston, Marie ;
Sudlow, Cathie ;
Dennis, Martin .
BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2011, 16 :592-609
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Treating an HIV/AIDS patient's PTSD and medication nonadherence with cognitive-behavioral therapy: A principle-based approach [J].
Chernoff, Robert A. .
COGNITIVE AND BEHAVIORAL PRACTICE, 2007, 14 (01) :107-117
[10]   Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals [J].
Delahanty, DL ;
Bogart, LM ;
Figler, JL .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2004, 16 (02) :247-260